Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation
2025/01/30 by Areesha Moiz, Kristian B. Filion, Michael A. Tsoukas +4 · 1 voice · 29 citations
Neuroscience · Medicine · #Regulation of Appetite and Obesity #Pharmacology and Obesity Treatment #Diet and metabolism studies
paper · pdf · doi:10.1016/j.amjmed.2025.01.021
Cited by
- Alcohol Use Following GLP-1 Receptor Agonist Therapy in the Cooper Center Longitudinal Study
- Semaglutide Exacerbates Stunting in Growth-Impaired Juvenile Male Mice via Reduced Energy Metabolism
- Effects of glucagon-like peptide-1 receptor agonists on metabolic outcomes in antipsychotic-treated patients with schizophrenia: A systematic review and meta-analysis
- GLP‐1 Receptor Agonists and Endoscopy: Understanding Gastric Stasis, Aspiration Risk, and Contemporary Peri‐Procedural Guidance
- The Influence of the Sympathetic Nervous System on Cardiometabolic Health in Response to Weight Gain or Weight Loss. [europepmc]
- Unintended Consequences of Obesity Pharmacotherapy: A Nutritional Approach to Ensuring Better Patient Outcomes. [europepmc]
- Optimizing Body Composition During Weight Loss: The Role of Amino Acid Supplementation. [europepmc]
- The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions. [europepmc]
- Type 2 Diabetes and the Multifaceted Gut-X Axes. [europepmc]
- Effect of semaglutide on arrhythmic, major cardiovascular, and renal outcomes in patients with overweight or obesity: a systematic review and meta-analysis. [europepmc]
- The Impact of Glucagon-like Peptide-1 Receptor Agonists on Erectile Function: Friend or Foe? [europepmc]
- GLP-1 Receptor Agonists in Mood Disorders: A Psychiatric Perspective. [europepmc]
- Predictive factors of body weight loss in patients with type 2 diabetes treated with GLP-1 receptor agonists: a 52-week prospective real-life study. [europepmc]
- Baseline characteristics in the SYNCHRONIZE™-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes. [europepmc]
- Semaglutide from Bench to Bedside: The Experimental Journey Towards a Transformative Therapy for Diabetes, Obesity and Metabolic Liver Disorders. [europepmc]
- Incretin-Based Therapies Through the Decades: Molecular Innovations and Clinical Impact. [europepmc]
- Effect of Semaglutide on Insulin Sensitivity and Cardiometabolic Risk Factors in Adolescents With Obesity: The STEP TEENS Study. [europepmc]
- Comparative Efficacy of Metabolic/Bariatric Surgery Versus GLP-1 Receptor Agonists: A Network Meta-Analysis of Randomized Controlled Trials. [europepmc]
- Muscle health in the modern era of incretin-based therapies. [europepmc]
- Macronutrient, Micronutrient Supplementation and Monitoring for Patients on GLP-1 Agonists: Can We Learn from Metabolic and Bariatric Surgery? [europepmc]
- Beyond Weight Loss: GLP-1 Usage and Appetite Regulation in the Context of Eating Disorders and Psychosocial Processes. [europepmc]
- 1,1-Diethoxyethane increases insulin sensitivity and ameliorates obesity and dyslipidemia in mice fed high-fat diet. [europepmc]
- Thermogenesis in Adipose Tissue: Adrenergic and Non-Adrenergic Pathways. [europepmc]
- The Combined Effect of Platelet-to-HDL-Cholesterol Ratio and Glycemic Metabolism Status on the Prognosis of Patients Undergoing Percutaneous Coronary Intervention: A Large-Scale Retrospective Cohort Study. [europepmc]
- Magnitude and Determinants of Weight Loss Response to GLP-1/GIP Receptor Agonists in India: A Real-World Time-to-Event Analysis. [europepmc]
- Weight maintenance after discontinuation of GLP-1 therapies. [europepmc]
- Association Between Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist Use and Blood Pressure Levels in Nondiabetic Obese Adults: A Cross-Sectional Analysis. [europepmc]
- Balancing metabolic optimization and reproductive safety in Polycystic Ovary Syndrome: a Bayesian-informed framework for GLP-1 receptor agonists. [europepmc]
- GLP-1 Agonists in Adolescent Obesity: A Narrative Review of Single, Dual, and Triple Agonists. [europepmc]
Discussions